Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,1476 USD | -2,25 % | +5,43 % | -24,31 % |
15/04 | CytoDyn Inc. informa de los resultados del tercer trimestre y los nueve meses finalizados el 29 de febrero de 2024 | CI |
05/03 | Transcript : CytoDyn Inc. - Special Call |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 65 | 17/11 | |
Mitchell Cohen
DFI | Director of Finance/CFO | 68 | 01/02 |
Scott Hansen
CTO | Chief Tech/Sci/R&D Officer | - | 03/05/23 |
Joseph Meidling
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/21 |
Melissa Palmer
CTO | Chief Tech/Sci/R&D Officer | - | 24/05/23 |
Cyrus Arman
COO | Chief Operating Officer | 43 | 09/07/22 |
Chief Tech/Sci/R&D Officer | 59 | 01/08/20 | |
Cristina de Leon
IRC | Investor Relations Contact | - | - |
Tyler Blok
LAW | General Counsel | 37 | 25/07/22 |
Seenu Srinivasan
LAW | General Counsel | - | 07/10/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Stephen Simes
BRD | Director/Board Member | 72 | 13/10/22 |
Ryan Dunlap
BRD | Director/Board Member | 54 | 24/08/22 |
Karen Brunke
BRD | Director/Board Member | 72 | 01/04/22 |
Lishomwa Ndhlovu
BRD | Director/Board Member | 54 | 24/11/21 |
Tanya Urbach
CHM | Chairman | 57 | 24/11/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 9 000 | 0 | 0 | 99,15 % |
Acción B | 0 | 6 000 | 0 | 0 | |
Acción C | 0 | 19 000 | 0 | 0 | |
Acción D | 1 | 993 809 000 | 985 393 715 ( 99,15 %) | 443 000 ( 0,0446 %) |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
-24,31 % | 150 M | |
+10,44 % | 106 mil M | |
+0,82 % | 104 mil M | |
+6,72 % | 23,25 mil M | |
-13,89 % | 22,5 mil M | |
-6,64 % | 18,7 mil M | |
-37,26 % | 17,95 mil M | |
-10,98 % | 16,99 mil M | |
+8,67 % | 14,26 mil M | |
+41,08 % | 12,76 mil M |
- Bolsa de valores
- Acciones
- Acción CYDY
- Empresa CytoDyn Inc.